Lexpos News

/Lexpos News

Pharmacy Show hears about work to drive better outcomes for sector

With negotiations on the 2026/27 Community Pharmacy Contractual Framework (CPCF) expected to begin this autumn, Community Pharmacy England CEO Janet Morrison gave an important sector update at this week’s Pharmacy Show. Janet outlined how Community Pharmacy England has been preparing for the upcoming CPCF negotiations and working to drive better outcomes for the sector. Drawing [...]

The post Pharmacy Show hears about work to drive better outcomes for sector appeared first on Community Pharmacy England.

By |October 15th, 2025|Lexpos News|Comments Off on Pharmacy Show hears about work to drive better outcomes for sector

Medicine Supply Notification: Dalivit® Oral Drops

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Dalivit® Oral Drops MSN/2025/055 Tier 2 – medium impact Date of issue: 15/10/2025 Dalivit® Oral Drops are out of stock until further notice. Abidec® Multivitamin Drops remain available and can support increased demand. A copy of this [...]

The post Medicine Supply Notification: Dalivit® Oral Drops appeared first on Community Pharmacy England.

By |October 15th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Dalivit® Oral Drops

Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. [...]

The post Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen appeared first on Community Pharmacy England.

By |October 15th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. [...]

The post Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen appeared first on Community Pharmacy England.

By |October 15th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

Our response to the BMA Pharmacy First letter

Pharmacy press In response to the letter critical of the Pharmacy First service, as reported in The Times article, BMA leaders suggest GPs ‘overwhelm A&Es’ in revolt against NHS reforms, we issued the following statement to the press. Our CEO, Janet Morrison said:  “We are very troubled by this combative approach and are writing to [...]

The post Our response to the BMA Pharmacy First letter appeared first on Community Pharmacy England.

By |October 10th, 2025|Lexpos News|Comments Off on Our response to the BMA Pharmacy First letter